Advertisement
OtherMinireview

Passive Immunotherapies Targeting Amyloid-β in Alzheimer's Disease: A Quantitative Systems Pharmacology Perspective

Milica Markovic, Jelica Milošević, Weirong Wang and Yanguang Cao
Molecular Pharmacology October 31, 2023, MOLPHARM-MR-2023-000726; DOI: https://doi.org/10.1124/molpharm.123.000726

Article Information

MOLPHARM-MR-2023-000726
DOI 
https://doi.org/10.1124/molpharm.123.000726
PubMed 
37907353
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online October 31, 2023.
Copyright & Usage 
Copyright © 2023 American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Milica Markovic1,
  2. Jelica Milošević2,
  3. Weirong Wang3, and
  4. Yanguang Cao4,*
  1. 1the University of North Carolina at Chapel Hill, United States
  2. 2University of Belgrade, Serbia
  3. 3Janssen Research & Development, LLC, United States
  4. 4THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, United States
  1. ↵* Corresponding Author:
    Yanguang Cao, THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, 301 Pharmacy Lane, CB 7569, Chapel Hill, North Carolina, 27599, United States. E-mail: yanguang{at}unc.edu

Statistics from Altmetric.com

Article usage

Article usage: October 2023 to November 2023

AbstractFullPdf
Oct 20232509
Nov 20234720284

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherMinireview

A QSP perspective of Passive Amyloid-β Immunotherapy

Milica Markovic, Jelica Milošević, Weirong Wang and Yanguang Cao
Molecular Pharmacology October 31, 2023, MOLPHARM-MR-2023-000726; DOI: https://doi.org/10.1124/molpharm.123.000726
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement